Philippe L. Bédard

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Supplementary Figure 4 from Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer

  2026-06-17

• Supplementary Figure 2 from Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer

  2026-06-17

• Supplementary Table 5 from Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer

  2026-06-17

• Supplementary Table 1 from Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer

  2026-06-17

• Supplementary Figure 3 from Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer

  2026-06-17

• Supplementary Table 3 from Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer

  2026-06-17

• Supplementary Table 2 from Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer

  2026-06-17

• Supplementary Figure 5 from Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer

  2026-06-17

• Supplementary Table 4 from Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer

  2026-06-17

• Supplementary Table 7 from Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer

  2026-06-17

• Supplementary Figure 1 from Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer

  2026-06-17

• Supplementary Table 6 from Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer

  2026-06-17

• Circulating Cell-Free DNA Methylation Profiling Enables Detection, Distinction, and Estrogen Receptor Status Classification of Advanced Breast Cancer

  Cancer Research · 2026-06-10

• Methylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapy

  Nature Communications · 2026-06-04

• Longitudinal evaluation of serial ctDNA kinetics using joint modeling in patients with metastatic breast cancer

  npj Precision Oncology · 2026-06-03

• Predicting immunotherapy benefit in leiomyosarcoma through active chromatin cfDNA profiling

  npj Precision Oncology · 2026-05-05

• Abstract CT045: Initial clinical and translational results and selection of recommended phase 2 dose (RP2D) from START-002: A Phase 1b/2 study of invikafusp alfa, a first-in-class dual T-cell agonist, in combination with sacituzumab govitecan in metastatic triple-negative or HR+/HER2- breast cancer

  Cancer Research · 2026-04-17

• The role of stereotactic body radiotherapy in oligoprogressive breast cancer: A site-specific analysis of the prospective, phase-II RADIANT trial

  Clinical and Translational Radiation Oncology · 2026-04-06

• Postchemotherapy orchiectomy in metastatic testicular germ cell tumors: Pathologic findings and predictors of residual viable disease

  Urologic Oncology Seminars and Original Investigations · 2026-04-03

• Abstract 3864: Serial ctDNA monitoring in metastatic breast cancer using an ultrasensitive tumor informed structural variant based assay.

  Cancer Research · 2026-04-03